Preliminary experience of lenvatinib, tislelizumab and transcatheter arterial chemoembolization for BCLC stage C hepatocellular carcinoma: a phase II study

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2025-10-22
DOI
https://doi.org/10.1186/s12885-025-15016-9
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Preliminary experience of lenvatinib, tislelizumab and transcatheter arterial chemoembolization for BCLC stage C hepatocellular carcinoma: a phase II study

Jingchang Liang, Jinlong Xie, Yumei Zhang, Zhiming Zhang et al.
BMC Cancer
Hepatocellular Carcinoma Treatment and Prognosis
article

Preliminary experience of lenvatinib, tislelizumab and transcatheter arterial chemoembolization for BCLC stage C hepatocellular carcinoma: a phase II study

Jingchang Liang, Jinlong Xie, Yumei Zhang, Zhiming Zhang, Xiang Nong, Yu Yao
article en

Abstract

No abstract available for this paper.
BMC CancerVol. 25(1)
Guangxi Medical University (CN), Tumor Hospital of Guangxi Medical University (CN)
Openalex Percentile: Top 60%
Hepatocellular Carcinoma Treatment and Prognosis
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.